Mylan Inc. (MYL)
Россия
  • Россия
  • Украина

Mylan Inc. (MYL)

Contact Details

1000 Mylan Blvd, Canonsburg, Pennsylvania, USA 15317-5853
(724) 514-1800
1000 Mylan Blvd, Canonsburg, Pennsylvania, USA 15317-5853

General Information

Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.

Contact Information

Phone(724) 514-1800
Customer Service Phone(724) 514-1800
Fax(724) 514-1870
Press Emailcommunications@mylan.com
Website 1http://www.mylan.com
LinkedInLinkedIn
Twitter@MylanNews
Thomson Reuters PermID5043331389

Products

Drug NameCondition
AMNESTEEMAcne
SULFAMYLON 5% TOPICAL SOLUTIONSkin infections (topicals)
SULFAMYLON CREAMSkin infections (topicals)

Executives

NamePositionTotal Annual CompensationYearPercent Change in Compensation
Robert J. CouryChairman of the Board$15,410,0002013-45.0%
Heather BreschCEO$9,047,1602013-9.2%
Mr. Rajiv MalikPresident$8,196,6012013-15.9%
Louis J. DeBoneFormer COO and Former President$3,966,2602007194.4%
John D. SheehanCFO and Executive VP$3,770,2832013-11.9%
Harry A. KormanCOO and Executive VP$2,856,8282013-11.3%
Didier BarretGeographical President$2,153,8332008
Dr.John P. O`Donnell, Ph.D.Former Chief Scientific Officer$2,058,7202007132.9%
Stuart A. WilliamsOther Executive Officer$2,033,1492007109.3%
Daniel C. Rizzo,JrCAO and Controller$1,272,57520105.5%
Jolene L. VarneyCFO$657,3412009
Milan PuskarChairman of the Board and Director$364,471200861.3%
Mr. Douglas J. LeechDirector$197,722200887.8%
Rodney L. PiattDirector and Vice Chairman of the Board$190,973200876.0%
C. B. ToddDirector Emeritus$178,638200878.2%

Government Contracts

Largest Contracts

AgencyProduct or ServiceSigned DateObligation Amount
Department of Veterans AffairsJune 07, 2006$240

Corporate Data

Industries

  • Pharmaceutical Preparation Manufacturing

SIC Industries

  • Pharmaceutical Preparations

Company Size

Sales Volume$9.43 billion
Employees35,000

Ownership

Ticker SymbolMYL
ExchangeNASDAQ Global Select Market
Year Founded1965

Stocks

Previous Close47.00
Open47.32
Bid45.54 x 8,300
Ask45.56 x 6,400
Day`s Range45.21 - 47.47
52-Week Range39.16 - 76.06
Average Volume (1M)4,458,867
Forward P/E9.59x
Trailing P/E11.03x
Beta1.26x
Market Cap.$23,062.3 Million
Last Dividend Amount0
1y Target Price Est.69

Financials

Period EndingDec. 31, 2015Sep. 30, 2015Jun. 30, 2015Mar. 31, 2015
Total Revenue2,490,6992,695,2002,371,7001,871,700
Cost of Revenue1,428,1001,379,9001,363,6001,041,600
Gross Profit1,062,5991,315,3001,008,100830,100
Research Development159,000174,800168,200169,900
Selling General and Administrative596,199.9537,100564,200483,200
Depreciation and Amortization----
Other Operating Expenses(116,499.9)2,300(900)17,700
Total Operating Expenses2,066,8002,094,1002,095,1001,712,400
Other Income/Expenses Net0.4---
Earnings Before Interest and Taxes423,900.1601,099.9276,599.9159,300
Interest Expense70,90095,10093,90079,500
Income Before Tax218,300455,100180,70061,300
Income Tax Expense23,70026,50012,8004,700
Minority Interest----
Net Income from Continuing Ops194,600428,600167,90056,600
Discontinued Operations----
Extraordinary Items----
Effect of Accounting Changes----
Other Items--(100)-
Net Income194,600428,600167,80056,600
Preferred Stock and Other Adjustments0.1---
Net Income Applicable to Common Shares194,600428,600167,80056,600